ArticleNucleic acids research2026
MassBank: an open and FAIR mass spectral data resource.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- ExpoLib: a framework for an MS/MS exposome library of anthropogenic and natural toxicants and their biotransformation products.Metabolomics : Official journal of the Metabolomic Society · 2026Article
- Reviving Data Potential─The Reanalysis-Driven Metabolomics Data Repository MB-POST.Analytical chemistry · 2026Article
- Chemical Profiling ofPharmaceuticals (Basel, Switzerland) · 2026Article
- The MassBank contributions of the mFam collaboration.Metabolomics : Official journal of the Metabolomic Society · 2026Article
- Differentiation of White and Red Galangal Rhizomes by Pseudo-Targeted LC-MS/MS Metabolomics.Chemistry & biodiversity · 2026Article
- The Variation and Influencing Factors of Volatile Organic Compounds on Branch and Leaf ofLife (Basel, Switzerland) · 2026Article
- A Two-Layer Structural Key Framework for Linking Compound Identifiers and MS/MS Evidence in Spectral Database Curation.Metabolites · 2026Article
- Librarian: An Open-Access Web Application for High-Resolution Mass Spectral Library Assembly.Metabolites · 2026Article
- A multiplatform chromatography-mass spectrometry dataset for targeted and suspect screening of pollutants.Scientific data · 2026Article
- Data-Driven Filter for Detector Oscillation Artifacts in Time-of-Flight Mass Spectrometry.Analytical chemistry · 2026Article
- Curation of Mass Spectrometry Reference Data for Improved Identification and Dereplication of Cyanobacterial Specialized Metabolites.Journal of natural products · 2026Article
- Will Chemical Exposomics Be Ready for a Human Exposome Project?Environmental science & technology · 2026Article
- Decoding the Metabolic Signatures of Neurodegeneration Diseases: Advances in Mass Spectrometry-Based Metabolomics.Metabolites · 2026Review
- Dual Evaluation ofJournal of clinical medicine · 2026Article
- Polymeric PLGA Nanoparticles Loaded withPharmaceutics · 2026Article
- Article
- The 2026 Nucleic Acids Research database issue and the online molecular biology database collection.Nucleic acids research · 2026Article
- Ershiwuwei Shanhu Pill ameliorates cognitive impairment in Alzheimer's disease mice by remodeling gut microbiota and host serum metabolites.Frontiers in aging neuroscience · 2026Article
- LC-MS-based serum metabolomics reveals distinct metabolic signatures in patients with intracerebral Hemorrhage.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
The open spectral library MassBank (https://massbank.jp/) started in 2006 in Japan, as one of the first open source and open access cross-vendor mass spectral libraries. The first dedicated European MassBank server (https://massbank.eu/) was launched in 2011, adding spectra from compounds of environmental relevance to complement the original metabolomics focus. Recent developments boosted the FAIRness of MassBank data, and a redesigned web interface with modern architecture was launched in 2025. All records are under version control, and versioned releases are pushed to an independent data repository with digital object identifier assigned to each data release. Semantic metadata integrates the spectral data into the world of linked open data. The record format enables many downstream studies, and records are validated by an automated pipeline to ensure data quality upon submission and review existing records. The SPectraL hASH was added for spectral content-based access. MassBank is cross-integrated in several resources such as MassBank of North America, Global Natural Product Social Molecular Networking, PubChem, the US EPA CompTox Dashboard, NORMAN Database System, RforMassSpectrometry, and more. MassBank now boasts a total of 119 845 spectra of 18 529 compounds from 53 contributors from around the world.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.